-
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
J Nucl Med. 2008 Mar;49(3):390-8
PMID: 18287270
-
The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.
Neurology. 1995 Nov;45(11):2077-84
PMID: 7501162
-
Cortical abnormalities in Alzheimer's disease.
Ann Neurol. 1984 Dec;16(6):649-54
PMID: 6335378
-
Severity of vascular dementia is related to volume of metabolically impaired tissue.
Arch Neurol. 1992 Sep;49(9):909-13
PMID: 1520079
-
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
Ann Neurol. 1997 Jul;42(1):85-94
PMID: 9225689
-
Age, neuropathology, and dementia.
N Engl J Med. 2009 May 28;360(22):2302-9
PMID: 19474427
-
PET studies in dementia.
Ann Nucl Med. 2003 Apr;17(2):79-89
PMID: 12790355
-
The role of biomarkers in clinical trials for Alzheimer disease.
Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15
PMID: 16493230
-
Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.
Eur J Nucl Med Mol Imaging. 2006 May;33(5):575-83
PMID: 16470370
-
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease.
Neuroimage. 2008 May 1;40(4):1503-15
PMID: 18343688
-
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
Brain. 2005 Aug;128(Pt 8):1790-801
PMID: 15888536
-
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
J Psychiatr Res. 1975 Nov;12(3):189-98
PMID: 1202204
-
Positron emission tomography imaging in dementia.
Br J Radiol. 2007 Dec;80 Spec No 2:S160-7
PMID: 18445746
-
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.
Neuroimage. 2002 Sep;17(1):302-16
PMID: 12482085
-
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10966-71
PMID: 11526211
-
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Lancet Neurol. 2007 Aug;6(8):734-46
PMID: 17616482
-
Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease.
J Neurol Sci. 2002 Aug 15;200(1-2):27-32
PMID: 12127672
-
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Brain. 2007 Oct;130(Pt 10):2616-35
PMID: 17704526
-
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment.
Mol Imaging Biol. 2002 Jul;4(4):283-93
PMID: 14537119
-
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?
Neurology. 2003 Apr 22;60(8):1374-7
PMID: 12707450
-
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.
J Nucl Med. 2007 Jul;48(7):1129-34
PMID: 17574982
-
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Arch Neurol. 2005 Nov;62(11):1728-33
PMID: 16286547
-
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
J Nucl Med. 2005 Oct;46(10):1625-32
PMID: 16204712
-
Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia.
J Neurol Neurosurg Psychiatry. 2003 Jun;74(6):715-9
PMID: 12754337
-
Clinical symptoms associated with age at onset in Alzheimer's disease.
Am J Psychiatry. 1994 Nov;151(11):1646-9
PMID: 7943455
-
Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease.
Neuroimage. 2009 Jun;46(2):472-85
PMID: 19385015
-
FDG PET imaging in patients with pathologically verified dementia.
J Nucl Med. 2000 Nov;41(11):1920-8
PMID: 11079505
-
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
J Nucl Med. 1995 Jul;36(7):1238-48
PMID: 7790950
-
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
JAMA. 2001 Nov 7;286(17):2120-7
PMID: 11694153
-
Hippocampal hypometabolism predicts cognitive decline from normal aging.
Neurobiol Aging. 2008 May;29(5):676-92
PMID: 17222480
-
On the multivariate nature of brain metabolic impairment in Alzheimer's disease.
Neurobiol Aging. 2009 Feb;30(2):186-97
PMID: 17651869
-
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.
Neurology. 2006 Aug 8;67(3):446-52
PMID: 16894106
-
Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease.
Arch Neurol. 1993 Apr;50(4):359-73
PMID: 8460957
-
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
Neurology. 1984 Jul;34(7):939-44
PMID: 6610841
-
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Arch Neurol. 1998 Mar;55(3):326-35
PMID: 9520006
-
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Am J Psychiatry. 2002 May;159(5):738-45
PMID: 11986126